No recent ownership filings for this insider.
| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | Aug 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 2.5 | -31,448 | -87.70% | ✓ | $13.7M |
| Aug 6, 2024 | Aug 8, 2024 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 3.8 | -20,250 | -84.78% | ✓ | $5.3M |
| Nov 21, 2022 | Nov 23, 2022 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -22,500 | -86.54% | ✓ | $5M |
| Mar 13, 2018 | Mar 14, 2018 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -17,117 | -83.02% | ✓ | $2.6M |
| Nov 2, 2017 | Nov 3, 2017 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -20,000 | -85.11% | ✓ | $2.6M |
| Apr 21, 2015 | Apr 23, 2015 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -8,165 | -70.00% | ✓ | $1.1M |
| Mar 19, 2015 | Mar 19, 2015 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 7.5 | -5,000 | -30.00% | ✓ | $600K |
| Mar 5, 2015 | Mar 6, 2015 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 37.5 | -706 | -4.06% | ✓ | $81.2K |
| Dec 8, 2014 | Dec 10, 2014 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -15,000 | -47.37% | ✓ | $1.6M |
| Nov 11, 2014 | Nov 13, 2014 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 12.5 | -5,000 | -23.08% | ✓ | $500K |
| Oct 22, 2014 | Oct 24, 2014 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 12.5 | -5,000 | -23.08% | ✓ | $450K |